132 related articles for article (PubMed ID: 32033849)
1. Lower respiratory infections mortality among Brazilians under-five before and after national pneumococcal conjugate vaccine implementation.
Camargos P; Nascimento-Carvalho CM; Teixeira R; França E
Vaccine; 2020 Mar; 38(11):2559-2565. PubMed ID: 32033849
[TBL] [Abstract][Full Text] [Related]
2. Effect of pneumococcal conjugate vaccines on mortality from lower respiratory infections and pneumonia among under-fives.
Camargos P; Zhang L; Nascimento-Carvalho CM
Hum Vaccin Immunother; 2021 Feb; 17(2):537-545. PubMed ID: 32730135
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: A time-series analysis.
Andrade AL; Minamisava R; Policena G; Cristo EB; Domingues CM; de Cunto Brandileone MC; Almeida SC; Toscano CM; Bierrenbach AL
Hum Vaccin Immunother; 2016; 12(2):285-92. PubMed ID: 26905679
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
5. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
[TBL] [Abstract][Full Text] [Related]
6. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in pneumococcal vaccination of children.
Russell FM; Mulholland EK
Ann Trop Paediatr; 2004 Dec; 24(4):283-94. PubMed ID: 15720885
[TBL] [Abstract][Full Text] [Related]
8. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
[TBL] [Abstract][Full Text] [Related]
9. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
[TBL] [Abstract][Full Text] [Related]
10. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
De Wals P; Black S; Borrow R; Pearce D
Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
[TBL] [Abstract][Full Text] [Related]
11. Can pneumococcal meningitis surveillance be used to assess the impact of pneumococcal conjugate vaccine on total invasive pneumococcal disease? A case-study from South Africa, 2005-2016.
Kleynhans J; Cohen C; McMorrow M; Tempia S; Crowther-Gibson P; Quan V; de Gouveia L; von Gottberg A;
Vaccine; 2019 Sep; 37(38):5724-5730. PubMed ID: 31076159
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China.
Mo X; Gai Tobe R; Liu X; Mori R
Pediatr Infect Dis J; 2016 Nov; 35(11):e353-e361. PubMed ID: 27753771
[TBL] [Abstract][Full Text] [Related]
14. Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil.
Grando IM; Moraes Cd; Flannery B; Ramalho WM; Horta MA; Pinho DL; Nascimento GL
Cad Saude Publica; 2015 Feb; 31(2):276-84. PubMed ID: 25760162
[TBL] [Abstract][Full Text] [Related]
15. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
Tsaban G; Ben-Shimol S
Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
[TBL] [Abstract][Full Text] [Related]
16. Bayesian Model Averaging with Change Points to Assess the Impact of Vaccination and Public Health Interventions.
Kürüm E; Warren JL; Schuck-Paim C; Lustig R; Lewnard JA; Fuentes R; Bruhn CAW; Taylor RJ; Simonsen L; Weinberger DM
Epidemiology; 2017 Nov; 28(6):889-897. PubMed ID: 28767518
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.
Delgleize E; Leeuwenkamp O; Theodorou E; Van de Velde N
BMJ Open; 2016 Nov; 6(11):e010776. PubMed ID: 27903558
[TBL] [Abstract][Full Text] [Related]
18. Use of Chest Radiography Examination as a Probe for Pneumococcal Conjugate Vaccine Impact on Lower Respiratory Tract Infections in Young Children.
Ben-Shimol S; Dagan R; Givon-Lavi N; Avital D; Bar-Ziv J; Greenberg D
Clin Infect Dis; 2020 Jun; 71(1):177-187. PubMed ID: 31414125
[TBL] [Abstract][Full Text] [Related]
19. Seasonality of both bacteremic and nonbacteremic pneumonia coincides with viral lower respiratory tract infections in early childhood, in contrast to nonpneumonia invasive pneumococcal disease, in the pre-pneumococcal conjugate vaccine era.
Ben-Shimol S; Greenberg D; Hazan G; Shemer-Avni Y; Givon-Lavi N; Dagan R
Clin Infect Dis; 2015 May; 60(9):1384-7. PubMed ID: 25595749
[TBL] [Abstract][Full Text] [Related]
20. Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era.
Anderson G; Deceuninck G; Zhou Z; Boucher FD; Bonnier Viger Y; Gilca R; De Wals P
Epidemiol Infect; 2017 Oct; 145(13):2770-2776. PubMed ID: 28803551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
